Navigation Links
FHSSA and the African Palliative Care Association Launch the First-Ever Pain Management Initiative in The Gambia, Kenya, and Malawi

ALEXANDRIA, Va., Feb. 9, 2011 /PRNewswire-USNewswire/ -- With generous funding totaling more than $220,000 FHSSA and the African Palliative Care Association are partnering to improve pain management among palliative care patients receiving care in hospitals in The Gambia, Kenya, and Malawi.

These three countries were selected because they each have well-established national palliative care organizations, strong clinical leadership, historical success with related projects, and sound professional relationships with APCA and FHSSA staff/leadership.

FHSSA's executive director, John Mastrojohn, traveled to Uganda this week to participate in kick-off meetings for the project.

FHSSA and APCA identified a set of challenges for the management of pain in The Gambia, Kenya, and Malawi. Hospital-based health care workers sometimes have a limited understanding of the palliative care concept and the need for palliative care services.

"Often, physicians are not comfortable in effectively prescribing opioids, such as morphine. This can be due to lack of skills in pain assessment and management, coupled with fears around the use of these powerful medications," said Mastrojohn.

The project framework is based on the success of a pilot project in Uganda that was endorsed by the World Health Organization and the Ugandan Ministry of Health. Objectives include:

  1. To create awareness of, support for and prioritization of palliative care delivery among hospital management/administrators.
  2. To train hospital physicians in pain assessment and management, with a central focus on opioid use.
  3. To sensitize other health care workers in the hospitals and community to support palliative care service delivery.

Funding was provided by Astellas Pharma US, Inc. , AstraZeneca Pharmaceuticals LP, Daiichi Sankyo, Inc., Endo Pharmaceuticals Inc., Lundbeck Inc, OSI Pharmaceuticals Inc., Pharmaceutical Research and Manufacturers of America (PhRMA), Grunenthal, and The Brin Wojcicki Foundation.

Learn more about the work of FHSSA at

The Winter issue of FHSSA's "Focus on Compassion" newsletter is available online at Contact:Susan MessinaDirector of Communications and Special EventsOffice of Philanthropy (National Hospice Foundation and FHSSA)

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices
2. Grammy Winner Marc Cohn to Perform for African AIDS Organization at Carolina HopeFest
3. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
6. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
7. Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials
8. Tampax and Always Launch Protecting Futures Program Dedicated to Helping African Girls Stay in School
9. New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline
10. Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa
11. Karmanos Cancer Institute Research Supports Role of Inflammation to Determine Lung Cancer Risk, Particularly in African-American Women
Post Your Comments:
(Date:11/25/2015)... 25, 2015  Trovagene, Inc. (NASDAQ: TROV ), ... Chief Executive Officer Antonius Schuh, Ph.D., is scheduled to ... Annual Piper Jaffray Healthcare Conference. th ... Palace Hotel in New York ... Mr. Schuh will be available for one-on-one meetings during ...
(Date:11/25/2015)... 2015 Allergan plc (NYSE: AGN ... Therapeutics, a start-up  biotechnology company focused on the ... and funded by the F-Prime Biomedical Research Initiative ... an exclusive collaboration to support the discovery and ... (ASD) and Obsessive Compulsive disorders (OCD). ...
(Date:11/25/2015)... Ohio , Nov. 25, 2015 ... handle hazardous drug preparations (e.g. pharmacists, pharmacy technicians, ... and veterinary technicians). The chapter also covers all ... drugs (e.g., pharmacies, hospitals, other healthcare institutions, patient ... --> --> ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... ... For the first time, Vitalalert is donating half of its earnings to ... between the two groups began in 2014 with Vitalalert pledging a portion of every ... founded in 1954 and is an international Christian-based health organization whose mission is to ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... encouraging people across the country to celebrate their sobriety and show through pictures ... post “before and after” photos this Thanksgiving with the hashtag #FacesOfGratitude on their ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 25, 2015, ... for the Narconon network, announced the release of a new cutting edge recovery program ... organization has been working with drug- and alcohol-addicted individuals with the purpose to free ...
(Date:11/25/2015)... ... 25, 2015 , ... The McHenry County law firm of Botto Gilbert ... Attorneys Francisco J. Botto and Alex C. Wimmer. Attorneys Botto and Wimmer represented the ... App (2d) 130884WC. , According to court documents, Adcock testified that on May 10, ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
Breaking Medicine News(10 mins):